Key terms

About TNYA

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TNYA news

Apr 05 6:56am ET Tenaya Therapeutics’ Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy Rating by TipRanks Mar 28 7:05am ET Optimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical Milestones by TipRanks Mar 21 8:50am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA) by TipRanks Mar 21 2:17am ET Buy Rating Affirmed for Tenaya Therapeutics: A Combination of Solid Financials and Promising Clinical Pipeline by TipRanks Mar 21 12:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 21 12:10am ET Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA) by TipRanks Mar 21 12:00am ET Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA) by TipRanks Mar 20 11:50pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 20 11:40pm ET Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Telix Pharmaceuticals Ltd. (TLPPF) by TipRanks Mar 20 11:30pm ET Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA) by TipRanks Mar 20 11:20pm ET Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sera Prognostics (SERA) by TipRanks Mar 20 11:10pm ET Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sera Prognostics (SERA) by TipRanks Mar 20 11:00pm ET Analysts Are Bullish on Top Healthcare Stocks: Sera Prognostics (SERA), Tenaya Therapeutics (TNYA) by TipRanks Mar 20 10:50pm ET Analysts Offer Insights on Healthcare Companies: Sera Prognostics (SERA) and Tenaya Therapeutics (TNYA) by TipRanks Mar 20 10:40pm ET Analysts Are Bullish on These Healthcare Stocks: Sera Prognostics (SERA), Tenaya Therapeutics (TNYA) by TipRanks Mar 20 10:30pm ET Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Sera Prognostics (SERA) by TipRanks Mar 20 7:05am ET Tenaya Therapeutics price target lowered to $18 from $19 at Canaccord by TipRanks Mar 20 2:00am ET Tenaya Therapeutics’ Financial Tightrope: Balancing Development Costs with Cash Reserves by TipRanks Mar 19 6:40am ET Analysts’ Top Healthcare Picks: Inventiva (IVA), Tenaya Therapeutics (TNYA) by TipRanks Mar 19 6:25am ET Buy Rating Justified by Tenaya Therapeutics’ Strong Financials and Promising Cardiovascular Pipeline Progress by TipRanks Mar 18 11:55pm ET TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA) by TipRanks Mar 18 4:11pm ET Tenaya Therapeutics reports Q4 EPS (40c), consensus (44c) by TipRanks Mar 18 8:35am ET Tenaya announces publication of TN-401 gene therapy preclinical data by TipRanks Feb 26 8:38am ET Tenaya Therapeutics announces publication of preclinical HDAC6 inhibitor data by TipRanks Feb 13 6:00am ET Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA) by TipRanks Feb 09 4:17am ET Tenaya Therapeutics Announces Speculative Offering Outlook by TipRanks Feb 09 4:17am ET Tenaya Therapeutics Secures $50 Million in Share Sale by TipRanks Feb 08 8:17am ET Tenaya Therapeutics prices 8.89M shares at $4.50 in underwritten offering by TipRanks Feb 08 8:15am ET Tenaya Therapeutics 8.888M share Secondary priced at $4.50 by TipRanks

No recent news articles are available for TNYA

No recent press releases are available for TNYA

TNYA Financials

1-year income & revenue

Key terms

TNYA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TNYA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel